Pulsenmore To Commence Trading on Nasdaq as it expands FDA-authorized Home Prenatal Ultrasound Devices in the U.S.
false
פלסאנמור בע"מ
2
380
PULSENMORE LTD
Corporation no:
515139129
15150
Israel Securities Authority
Tel Aviv Stock Exchange
C002
(
Public
)
Reported via MAGNA:
21/01/2026
www.isa.gov.il
www.tase.co.il
Reference:
2026-02-008651
Time of broadcast:
15:23
15:23
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
Pulsenmore To Commence Trading on Nasdaq as it expands FDA-authorized Home Prenatal Ultrasound Devices in the U.S.
Form6K_Nadaq_Trading_isa.pdf
The report was signed by: Dr. Elazar Sonnenschein and Adv. Michael Hamelsdorf, Legal Counsel & Company Secretary
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
פלסאנמור
Date of revision of form structure:
06/08/2024
Address:
Omerim
8
,
Omer
8496500
,
Tel:
054-4499606
,
Fax:
08-6900466
E-mail address:
michaelh@pulsenmore.com
Company site:
https://pulsenmore.com/
Previous names of reporting entity:
Name of the Signatory:
Hamelsdorf Michael
Position of Signatory in the reporting corporation:
Legal Consultant & Corporate Secretary
Name of Employer Company:
Address:
Omerim
8
,
Omer
8496500
Telephone:
054-4499606
Facsimile:
E-mail:
MichaelH@Pulsenmore.com
1